Interview with Sejelas Founder-CEO interview series

Your experience spans the globe. Tell us more about your background.

I am the CEO and Founder of Rosetta Omics: an innovative deeptech healthcare startup incubated at Agoranov and in a mission to unlock the road to precision medicine using spatial multiomics and AI and starting with cancer. 

Having lived in four countries: Egypt, the Netherlands, USA and now France & studied in 13 total (in 5 continents), I acquired a multidimensional, multidisciplinary and multicultural understanding of the complexities that may rise in any life sciences biopharma/health organization and developed the ability to approach them with an innovative problem-solving attitude. My bachelor was from Egypt, my master was from the Netherlands, my PhD, from the USA, my postdoc from France and I did an executive MBA from ESCP business school between nine countries. 

Before Rosetta Omics, I founded a management consulting company called : Awad & Co. 

I served as the Chief Business Officer and board member of a French American Biotech and CRO CILcare (based in Paris, Boston, Montpellier and Copenhagen).  

I also led an in residence entrepreneurship project at CIlcare called DiagOtology (a clinical business unit based on auditory biomarkers that was planned to be spined out as a separate company).
I am elected and I serve in the board of directors of: Paris Saclay Cancer Cluster Connect, Medicen Paris region, ESCP Business School alumni Association, and the American University Club. 

I also have passion for academic teaching and I teach in multiple business schools and universities in France as a visiting/invited professor. I held a tenure track Assistant Professor position at Cairo University, Egypt for many years before I resign to focus on building Rosetta Omics.

In Egypt, in 2011, I was elected spokesperson for the Egyptian universities academic staff as I also co-founded the national association of young academic staff during the revolution and served as the minister of planning and international collaboration for the shadow cabinet for some years. I left politics 6 years ago to focus all my energy on building impactful companies in healthcare.

Congratulations on winning 1st place among 20 top European companies at the 6th HealthTech Innovation Days in Paris. How did the team achieve this? 

Thank you. 

Innovation is in the core of Rosetta Omics. We know that to be able to solve a mysterious and complex disease, we had to push the boundaries of science and use the most disruptive innovation.